Association between the use of midazolam, fentanyl, propofol, ketamine, and dexmedetomidine and the incidence of delirium in elderly patients in intensive care units: a systematic review
Open Access
- 1 January 2025
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 143 (6) , e20240311
Abstract
BACKGROUND: Delirium is a common and serious complication among elderly patients in intensive care units (ICUs), and is often associated with increased morbidity and mortality rates. The choice of sedoanalgesic may influence the incidence of delirium; however, the evidence remains unclear, particularly in the elderly population. OBJECTIVES: To evaluate the association between the use of different sedoanalgesics and the incidence of delirium in elderly ICU patients, based on data from randomized clinical trials. DESIGN AND SETTING: This systematic review was conducted using data from randomized clinical trials performed in various ICU settings. METHODS: A systematic search of the MEDLINE, Embase, and CENTRAL databases was performed in January 2024. The review included randomized clinical trials involving patients aged 60 years or older that examined the relationship between sedoanalgesics (midazolam, fentanyl, propofol, ketamine, and dexmedetomidine) and delirium incidence. Studies involving COVID-19 patients and non-randomized studies were excluded. RESULTS: A total of 1,331 patients from six studies were included. The mean age of the patients ranged from 71 to 74.7 years. Four studies compared dexmedetomidine with propofol; two found no significant difference in delirium incidence, whereas two suggested a lower incidence with dexmedetomidine. The remaining studies compared propofol with ketamine and dexmedetomidine with midazolam and showed no significant differences in the incidence of delirium. CONCLUSIONS: Dexmedetomidine may be associated with a lower incidence of delirium than propofol or midazolam in elderly ICU patients. However, further research is needed to confirm these findings and explore the factors contributing to delirium in this population. SYSTEMATIC REVIEW REGISTRATION: Registered with PROSPERO, CRD42024575693, available at https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=575693.Keywords
This publication has 40 references indexed in Scilit:
- Benzodiazepine and opioid use and the duration of intensive care unit delirium in an older population*Critical Care Medicine, 2009
- Implementation, reliability testing, and compliance monitoring of the Confusion Assessment Method for the Intensive Care Unit in trauma patientsIntensive Care Medicine, 2008
- Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trialCritical Care, 2006
- Lorazepam Is an Independent Risk Factor for Transitioning to Delirium in Intensive Care Unit PatientsAnesthesiology, 2006
- A Prospective Study of Agitation in a Medical-Surgical ICUChest, 2005
- Delirium as detected by the CAM-ICU predicts restraint use among mechanically ventilated medical patients*Critical Care Medicine, 2005
- Sample size calculations in randomised trials: mandatory and mysticalThe Lancet, 2005
- Multicentre study of delirium in ICU patients using a simple screening toolAustralian Critical Care, 2005
- Evaluation of delirium in critically ill patients: Validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)Critical Care Medicine, 2001
- Frequency, Severity, and Treatment of Agitation in Young versus Elderly Patients in the ICUPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000